Can Any DNA Claims Still Be Patented?
By EsqSocial Corporation 22/01/15
In a decision issued December 17, 2014, in In Re BRCA1- And BRCA2-Based Hereditary Cancer Test Patent Litigation (Myriad II), the Federal Circuit invalidated Myriad’s primer claims and detection method claims under 35 USC § 101. I first reported the...
By: Foley & Lardner LLP